[1]
|
(2017) Monitoring and Evaluation for Viral Hepatitis B and C: Recommended Indicators and Framework. Technical Report, World Health Organization, Geneva.
http://apps.who.int/iris/bitstream/10665/204790/1/9789241510288_eng.pdf
|
[2]
|
Ionita, G., Malviya, A., Rajbhandari, R., Schluter, W.W., Sharma, G., Kakchapati, S., Rijal, S. and Dixit, S. (2017) Seroprevalence of Hepatitis B Virus and Hepatitis C Virus Co-Infection among People Living with HIV/AIDS Visiting Antiretroviral Therapy Centres in Nepal: A First Nationally Representative Study. International Journal of Infectious Diseases, 60, 64-69. https://doi.org/10.1016/j.ijid.2017.04.011
|
[3]
|
Matthews, P.C., Geretti, A.M., Goulder, P.J.R. and Klenerman, P. (2014) Epidemiology and Impact of HIV Coinfection with Hepatitis B and Hepatitis C Viruses in Sub-Saharan Africa. Journal of Clinical Virology, 61, 20-33.
https://doi.org/10.1016/j.jcv.2014.05.018
|
[4]
|
Hawkins, C., Christian, B., Ye, J., Nagu, T., Aris, E., Chalamilla, G., et al. (2013) Prevalence of Hepatitis B Co-Infection and Response to Antiretroviral Therapy among HIV-Infected Patients in Tanzania. AIDS, 276, 919-927.
https://doi.org/10.1097/QAD.0b013e32835cb9c8
|
[5]
|
Wu, J.C., Huang, Y.H., Chau, G.Y., Su, C.W., Lai, C.R., Lee, P.C., et al. (2009) Risk Factors for Early and Late Recurrence in Hepatitis B-Related Hepatocellular Carcinoma. Journal of Hepatology, 51, 890-897.
https://doi.org/10.1016/j.jhep.2009.07.009
|
[6]
|
Stabinski, L., O’Connor, S., Barnhart, M., Kahn, R.J. and Hamm, T.E. (2015) Prevalence of HIV and Hepatitis B Virus Co-Infection in Sub-Saharan Africa and the Potential Impact and Program Feasibility of Hepatitis B Surface Antigen Screening in Resource-Limited Settings. JAIDS Journal of Acquired Immune Deficiency Syndromes, 68, S274-S285.
|
[7]
|
Kabinda, J.M., Michèle, D.-W., Donnen, P., Miyanga, S.A. and Van den Ende, J. (2014) Factors for Viral Infection in Blood Donors of South Kivu in the Democratic Republic of Congo. Pan African Medical Journal, 19, 385.
https://doi.org/10.11604/pamj.2014.19.385.4328
|
[8]
|
KabindaMaotela, J., Ramazani, S.Y., Misingi, P. and Dramaix-Wilmet, M. (2015) Blood Transfusion in the Democratic Republic of Congo: Efforts and Challenges. Médecine et Santé Tropicales, 25, 342-349.
|
[9]
|
Namululi, B.A., Guerrieri, C. and Dramaix, M. (2012) Impact of Method of Recruitment of Blood Donors on the Prevalence of HIV and HBV in Bukavu, DR Congo. Medicine et Santé Tropicales, 1, 69-74.
|
[10]
|
Batina, A., Kabemba, S. and Malengela, R. (2007) Marqueurs infectieux chez les donneurs de sang en République Démocratique du Congo (RDC). Revue Médicale de Bruxelles, 28, 145-149.
|
[11]
|
Kakisingi, C.N., Mukuku, O., Matanda, S.K., Manika, M.M., Kyabu, V.K., Kasamba, E.I., et al. (2016) Profil épidémiologique et séroprévalence des donneurs de sang aux cliniques universitaires de Lubumbashi, République Démocratique du Congo. Pan African Medical Journal, 23, 175. https://doi.org/10.11604/pamj.2016.23.175.8480
|
[12]
|
Kabinda, J.-M. and Katchunga, B.-P. (2010) Les hépatites virales B et C chez les porteurs du virus de l’immunodéficience humaine à Bukavu (Sud-Kivu), République démocratique du Congo. Journal Africain d’Hépato-Gastroentérologie, 4, 230-235.
https://doi.org/10.1007/s12157-010-0204-8
|
[13]
|
Shindano, T.A., Kabinda, J.M., Mitashi, P. and Horsmans, Y. (2018) Hepatitis B Virus Infection in the Democratic Republic of Congo: A Systematic Review of Prevalence Studies (2000-2016). Journal of Public Health, 26, 595-603.
https://doi.org/10.1007/s10389-018-0894-8
|
[14]
|
Day, S.L., Odem-Davis, K., Mandaliya, K.N., Jerome, K.R., Cook, L., et al. (2013) Prevalence, Clinical and Virologic Outcomes of Hepatitis B Virus Co-Infection in HIV-1 Positive Kenyan Women on Antiretroviral Therapy. PLoS ONE, 8, e59346.
https://doi.org/10.1371/journal.pone.0059346
|
[15]
|
Kfutwah, A.K., Tejiokem, M.C. and Njouom, R. (2012) A Low Proportion of HBeAg among HBsAg-Positive Pregnant Women with Known HIV Status Could Suggest Low Perinatal Transmission of HBV in Cameroon. Virology Journal, 9, 62.
https://doi.org/10.1186/1743-422X-9-62
|
[16]
|
Wandeler, G., Musukuma, K., Zurcher, S., Vinikoor, M.J., Llenas-Garcia, J., Aly, M.M., et al. (2016) Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia. PLoS ONE, 11, e0152043.
https://doi.org/10.1371/journal.pone.0152043
|
[17]
|
Ocama, P., Seremba, E., Apica, B. and Opio, K. (2015) Hepatitis B and HIV Co-Infection Is Still Treated Using Lamivudine Only Antiretroviral Therapy Combination in Uganda. African Health Sciences, 15, 328-333. https://doi.org/10.4314/ahs.v15i2.4
|
[18]
|
Laurent, C., Bourgeois, A., Mpoudi-Ngole, E., Kouanfack, C., Ciaffi, L., et al. (2010) High Rates of Active Hepatitis B and C Co-Infections in HIV-1 Infected Cameroonian Adults Initiating Antiretroviral Therapy. HIV Medicine, 11, 85-89.
https://doi.org/10.1111/j.1468-1293.2009.00742.x
|
[19]
|
Zoufaly, A., Onyoh, E., Tih, P., Awasom, C. and Feldt, T. (2012) High Prevalence of Hepatitis B and Syphilis Co-Infections among HIV Patients Initiating Antiretroviral Therapy in the North-West Region of Cameroon. International Journal of STD & AIDS, 23, 435-438. https://doi.org/10.1258/ijsa.2011.011279
|
[20]
|
Sagoe, K.W., Agyei, A.A., Ziga, F., Lartey, M., et al. (2012) Prevalence and Impact of Hepatitis B and C Virus Co-Infections in Antiretroviral Treatment Naive Patients with HIV Infection at a Major Treatment Centre in Ghana. Journal of Medical Virology, 84, 6-10. https://doi.org/10.1002/jmv.22262
|
[21]
|
Molu, J.P., Essome, M.C.N., Monamele, C.G. and Njouom, R. (2018) Sero-Prevalence of HBsAg in Naive HIV-Infected Patients in a Rural Locality of Cameroon. BMC Research Notes, 11, 39. https://doi.org/10.1186/s13104-018-3159-2
|
[22]
|
Kouanfack, C., Kowo, M., Haddison, E.S., Aletum, V.M., Takou, D., Awoumou, P., Tchokonte, S.C., Sosso, S., Oudou, N. and Torimiro, J.N. (2018) Undiagnosed Chronic Hepatitis B Infection and HIV Type 1 Drug Resistance Profile in AIDS Patients Receiving Tenofovir-Containing Antiretroviral Regimens: Considerations for Monitoring Resistant HIV Variants during Treatment. Microbiology Research Journal International, 23, 1-8. https://doi.org/10.9734/MRJI/2018/40801
|
[23]
|
Chambal, L.M., SamoGudo, E., Carimo, A., Corte Real, R., Mabunda, N., Maueia, C., et al. (2017) HBV Infection in Untreated HIV-Infected Adults in Maputo, Mozambique. PLoS ONE, 12, e0181836. https://doi.org/10.1371/journal.pone.0181836
|
[24]
|
Bivigou-Mboumba, B., Rouet, F., Mouinga-Ondeme, A., Deleplancque, L., Sica, J., Ndjoyi-Mbiguino, A., Njouom, R. and Francois-Souquière, S. (2017) Hepatitis B, C, and E Infection among HIV-Infected Patients in Franceville, Gabon: Retrospective Cross-Sectional Study. Médecine et Santé Tropicales, 27, 274-280.
|
[25]
|
Agyeman, A.A. and Ofori-Asenso, R. (2016) Prevalence of HIV and Hepatitis B Coinfection in Ghana: A Systematic Review and Meta-Analysis. AIDS Research and Therapy, 13, 23. https://doi.org/10.1186/s12981-016-0107-x
|
[26]
|
Geretti, A.M., Patel, M., Sarfo, F.S., Chadwick, D., Verheyen, J., Fraune, M., Garcia, A. and Phillips, R.O. (2010) Detection of Highly Prevalent Hepatitis B Virus Coinfection among HIV-Seropositive Persons in Ghana. Journal of Clinical Microbiology, 48, 3223-3230. https://doi.org/10.1128/JCM.02231-09
|
[27]
|
Hoffmann, C.J., Charalambous, S., Martin, D.J., Innes, C., Churchyard, G.J., Chaisson, R.E., Grant, A.D., Fielding, K.L. and Thio, C.L. (2008) Hepatitis B Virus Infection and Response to Antiretroviral Therapy (ART) in a South African ART Program. Clinical Infectious Diseases, 47, 1479-1485. https://doi.org/10.1086/593104
|
[28]
|
Dovonou, C.A., Amidou, S.A., Kpangon, A.A., Traore, Y.A., Godjedo, T.P., Satondji, A.J., et al. (2015) Prevalence of Hepatitis B in People Infected with HIV in Parakou in Benin. Pan African Medical Journal, 20, 125.
https://doi.org/10.11604/pamj.2015.20.125.6061
|
[29]
|
Rusine, J., Ondoa, P., Asiimwe-Kateera, B., Boer, K.R., Uwimana, J.M., et al. (2013) High Seroprevalence of HBV and HCV Infection in HIV-Infected Adults in Kigali, Rwanda. PLoS ONE, 8, e63303. https://doi.org/10.1371/journal.pone.0063303
|
[30]
|
Barth, R.E., Huijgen, Q., Taljaard, J. and Hoepelman, A.I. (2010) Hepatitis B/C and HIV in Sub-Saharan Africa: An Association between Highly Prevalent Infectious Diseases. A Systematic Review and Meta-Analysis. International Journal of Infectious Diseases, 14, e1024-e1031. https://doi.org/10.1016/j.ijid.2010.06.013
|
[31]
|
Diwe, C.K., Okwara, E.C., Enwere, O.O., Azike, J.E. and Nwaimo, N.C. (2013) Sero-Prevalence of Hepatitis B Virus and Hepatitis C Virus among HIV Patients in a Suburban University Teaching Hospital in South-East Nigeria. Pan African Medical Journal, 16, 7. https://doi.org/10.11604/pamj.2013.16.7.3077
|
[32]
|
Pirillo, M.F., Bassani, L., Germinario, E.A., Mancini, M.G., Vyankandondera, J., et al. (2007) Seroprevalence of Hepatitis B and C Viruses among HIV-Infected Pregnant Women in Uganda and Rwanda. Journal of Medical Virology, 79, 1797-1801.
https://doi.org/10.1002/jmv.21007
|
[33]
|
Masarone, M., De Renzo, A., La Mura, V., et al. (2014) Management of the HBV Reactivation in Isolated HBcAb Positive Patients Affected with Non Hodgkin Lymphoma. BMC Gastroenterology, 14, 31.
https://doi.org/10.1186/1471-230X-14-31
|
[34]
|
Neau, D., Winnock, M., Galperine, T., et al. (2004) Isolated Antibodies against the Core Antigen of Hepatitis B Virus in HIV-Infected Patients. HIV Medicine, 5, 171-173.
https://doi.org/10.1111/j.1468-1293.2004.00206.x
|
[35]
|
Landrum, M.L., Roediger, M.P., Fieberg, A.M., et al. (2011) Development of Chronic Hepatitis B Virus Infection in Hepatitis B Surface Antigen Negative HIV/HBV Co-Infected Adults: A Rare Opportunistic Illness. Journal of Medical Virology, 83, 1537-1543. https://doi.org/10.1002/jmv.22155
|
[36]
|
Majzoobi, M.M., Mamani, M., Hashemi, S.H., et al. (2018) Isolated Hepatitis B Core Antibody in HIV Infected Patients—Can Response to Hepatitis B Vaccine Help to Elucidate the Cause? Caspian Journal of Internal Medicine, 9, 328-333.
|
[37]
|
Liang, S.H., Chen, T.J., Lee, S.S., et al. (2010) Risk Factors of Isolated Antibody against Core Antigen of Hepatitis B Virus: Association with HIV Infection and Age But Not Hepatitis C Virus Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes, 54, 122-128. https://doi.org/10.1097/QAI.0b013e3181daafd5
|
[38]
|
Nebbia, G., Garcia-Diaz, A., Ayliffe, U., Smith, C., Dervisevic, S., et al. (2007) Predictors and Kinetics of Occult Hepatitis B Virus Infection in HIV-Infected Persons. Journal of Medical Virology, 79, 1464-1471. https://doi.org/10.1002/jmv.20954
|
[39]
|
Shire, N.J., Rouster, S.D., Rajici, N. and Sherman, K.E. (2004) Occult Hepatitis B in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes, 36, 869-875. https://doi.org/10.1097/00126334-200407010-00015
|
[40]
|
Chadwick, D., Stanley, A., Sarfo, S., Appiah, L., Ankcorn, M., et al. (2013) Response to Antiretroviral Therapy in Occult Hepatitis B and HIV Co-Infection in West Africa. AIDS, 27, 139-141. https://doi.org/10.1097/QAD.0b013e3283589879
|
[41]
|
Firnhaber, C., Viana, R., Reyneke, A., Schultze, D., Malope, B., et al. (2009) Occult Hepatitis B Virus Infection in Patients with Isolated Core Antibody and HIV Coinfection in an Urban Clinic in Johannesburg, South Africa. International Journal of Infectious Diseases, 13, 488-492. https://doi.org/10.1016/j.ijid.2008.08.018
|
[42]
|
Lewin, S.R., Ribeiro, R.M., Avihingsanon, A., Bowden, S., Matthews, G., Marks, P., Locarnini, S.A., Ruxrungtham, K., Perelson, A.S. and Dore, G.J. (2009) Viral Dynamics of Hepatitis B Virus DNA in Human Immunodeficiency Virus-1-Hepatitis B Virus Coinfected Individuals: Similar Effectiveness of Lamivudine, Tenofovir, or Combination Therapy. Hepatology, 49, 1113-1121.
https://doi.org/10.1002/hep.22754
|
[43]
|
Boyd, A., Gozlan, J., Miailhes, P., Lascoux-Combe, C., Cam, M.S., Rougier, H., et al. (2015) Rates and Determinants of Hepatitis B “e” Antigen and Hepatitis B Surface Antigen Seroclearance during Long-Term Follow-Up of Patients Coinfected with HIV and Hepatitis B Virus. AIDS, 29, 1963-1973.
https://doi.org/10.1097/QAD.0000000000000795
|
[44]
|
De Vries-Sluijs, T.E., Reijnders, J.G., Hansen, B.E., Zaaijer, H.L., Prins, J.M., Pas, S.D., et al. (2010) Long-Term Therapy with Tenofovir Is Effective for Patients Co-Infected with Human Immunodeficiency Virus and Hepatitis B Virus. Gastroenterology, 139, 1934-1941. https://doi.org/10.1053/j.gastro.2010.08.045
|
[45]
|
Domaoal, R.A., McMahon, M., Thio, C.L., Bailey, C.M., Tirado-Rives, J., Obikhod, A., et al. (2008) Pre-Steady-State Kinetic Studies Establish Entecavir 5’-Triphosphate as a Substrate for HIV-1 Reverse Transcriptase. The Journal of Biological Chemistry, 283, 5452-5459. https://doi.org/10.1074/jbc.M707834200
|
[46]
|
Doranz, B.J., Berson, J.F., Rucker, J. and Doms, R.W. (1997) Chemokine Receptors as Fusion Cofactors for Human Immunodeficiency Virus Type 1 (HIV-1). Immunologic Research, 16, 15-28. https://doi.org/10.1007/BF02786321
|
[47]
|
Sinicco, A., Raiteri, R., Sciandra, M., Bertone, C., Lingua, A., Salassa, B., et al. (1997) Coinfection and Superinfection of Hepatitis B Virus in Patients Infected with Human Immunodeficiency Virus: No Evidence of Faster Progression to AIDS. Scandinavian Journal of Infectious Diseases, 29, 111-115.
https://doi.org/10.3109/00365549709035869
|